Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
S. Nick
Observed names:
S Nick,
Sperelakis Nick
Observed institutions:
Merck KGaA, Darmstadt (Germany),
German Cancer Research Center,
University of Cincinnati Medical Center
OpenAlex ID:
A5113499664
An open-label pilot study of vemurafenib in previously treated metastatic melanoma patients with brain metastases.
2011
·
R. Dummer
, J. Rinderknecht
, et al.
·
Journal of Clinical Oncology
·
61
Taurine prevention of calcium paradox-related damage in cardiac muscle
1988
·
Yamauchi-Takihara Keiko
, Azuma Junichi
, et al.
·
Biochemical Pharmacology
·
35
Suppression of cytotoxic T lymphocyte activation by l -ornithine.
1985
·
W Dröge
, D Männel
, et al.
·
The Journal of Immunology
·
18
PDF
Phenotypic and functional characterization of tumor infiltrating y8 T lymphocytes derived from a melanoma patient
1993
·
C. S. Jaggle
, C. Ilsemann
, et al.
·
Melanoma Research
Bispecific antibody mediated T cell killing of melanoma cells
1993
·
C. S. Jaggle
, H. -G. Kreysch
, et al.
·
Melanoma Research
Show more works
View as search
Works count:
5
Citation count:
114
H-index:
3
I10-index:
3
Year
Topic
Type
